[go: up one dir, main page]

MXPA05013290A - Composiciones oftalmicas que contienen una combinacion sinergistica de dos polimeros. - Google Patents

Composiciones oftalmicas que contienen una combinacion sinergistica de dos polimeros.

Info

Publication number
MXPA05013290A
MXPA05013290A MXPA05013290A MXPA05013290A MXPA05013290A MX PA05013290 A MXPA05013290 A MX PA05013290A MX PA05013290 A MXPA05013290 A MX PA05013290A MX PA05013290 A MXPA05013290 A MX PA05013290A MX PA05013290 A MXPA05013290 A MX PA05013290A
Authority
MX
Mexico
Prior art keywords
polymers
compositions containing
ophthalmic compositions
synergistic combination
ophthalmic
Prior art date
Application number
MXPA05013290A
Other languages
English (en)
Inventor
Huagang Chen
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33539082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA05013290(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MXPA05013290A publication Critical patent/MXPA05013290A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen composiciones oftalmicas adecuadas para su uso como gotas artificiales o como vehiculos para farmacos oftalmicos; las composiciones contienen una combinacion de dos polimeros que tienen un efecto sinergistico sobre la viscosidad.
MXPA05013290A 2003-06-13 2004-06-08 Composiciones oftalmicas que contienen una combinacion sinergistica de dos polimeros. MXPA05013290A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47825303P 2003-06-13 2003-06-13
PCT/US2004/018068 WO2004112836A2 (en) 2003-06-13 2004-06-08 Ophthalmic compositions containing a synergistic combination of two polymers

Publications (1)

Publication Number Publication Date
MXPA05013290A true MXPA05013290A (es) 2006-03-09

Family

ID=33539082

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05013290A MXPA05013290A (es) 2003-06-13 2004-06-08 Composiciones oftalmicas que contienen una combinacion sinergistica de dos polimeros.

Country Status (16)

Country Link
US (1) US7709012B2 (es)
EP (5) EP2361610B1 (es)
JP (4) JP4860475B2 (es)
KR (5) KR20120062846A (es)
CN (1) CN100475192C (es)
AU (2) AU2004249137B2 (es)
BR (1) BRPI0411361B1 (es)
CA (6) CA2839847C (es)
DK (1) DK2116227T3 (es)
ES (3) ES2415738T3 (es)
MX (1) MXPA05013290A (es)
PL (1) PL2116227T3 (es)
PT (1) PT2116227E (es)
SI (1) SI2116227T1 (es)
WO (1) WO2004112836A2 (es)
ZA (1) ZA200509440B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7759296B2 (en) * 2003-06-19 2010-07-20 Lubrizol Advanced Materials, Inc. Cationic polymers and fixative application therefor
KR20120005052A (ko) * 2003-08-21 2012-01-13 수캄포 아게 안과용 조성물
AR062046A1 (es) 2006-07-25 2008-08-10 Osmotica Pharmaceutical Argentina S A Soluciones oftalmicas
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
US8138156B2 (en) * 2006-10-18 2012-03-20 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
BRPI0806967A2 (pt) * 2007-02-09 2014-04-08 Alcon Inc Composições oftálmicas contendo uma combinação sinérgica de três polímeros
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
KR20100031608A (ko) 2007-06-26 2010-03-23 와카모토 세이야꾸 가부시끼가이샤 수성 조성물
DK2193795T3 (da) 2007-08-29 2014-11-03 Wakamoto Pharma Co Ltd Latanoprostholdig vandig farmaceutisk sammensætning
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
WO2009110009A2 (en) * 2008-03-07 2009-09-11 Sun Pharma Advanced Research Company Ltd., Opthalmic composition
US8629099B2 (en) * 2008-03-25 2014-01-14 Bausch & Lomb Incorporated Ophthalmic compositions comprising a dipeptide
US20100286010A1 (en) * 2008-09-03 2010-11-11 Erning Xia Ophthalmic Compositions with Hyaluronic Acid
US20100178317A1 (en) * 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
WO2011018800A2 (en) * 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
CA2833591A1 (en) * 2011-04-22 2012-10-26 Alcon Research, Ltd. Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
SG11201403013VA (en) * 2011-12-07 2014-07-30 Allergan Inc Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US8664180B2 (en) 2012-02-06 2014-03-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US8324171B1 (en) 2012-02-06 2012-12-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
UA113434C2 (uk) * 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
HUE048564T2 (hu) * 2015-01-26 2020-08-28 Bausch & Lomb Szemészeti szuszpenzió készítmény
EP3310363A4 (en) * 2015-06-18 2019-02-13 Common Pharma, Inc ANTIMICROBIAL FORMULATIONS
JP6132968B1 (ja) * 2016-01-29 2017-05-24 参天製薬株式会社 ドルゾラミド、高分子およびホウ酸を含有する医薬組成物
US11331390B2 (en) 2016-04-22 2022-05-17 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
CN109069421B (zh) * 2016-04-22 2021-10-12 乐敦制药株式会社 眼科组合物
JP7297308B2 (ja) 2016-08-19 2023-06-26 オラシス ファーマシューティカルズ リミティド 眼科用医薬組成物及びそれに関する使用
JP7526718B2 (ja) * 2019-02-27 2024-08-01 参天製薬株式会社 ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物
WO2024180453A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Dissolvable polymeric eye inserts with a non-ionic cellulose derivative
WO2024180472A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Ocular inserts

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3355336A (en) * 1966-08-18 1967-11-28 Du Pont Thickened water-bearing inorganic oxidizer salt explosive containing crosslinked galactomannan and polyacrylamide
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4039662A (en) * 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
DE3440352A1 (de) * 1984-11-05 1986-05-07 Dr. Thilo & Co GmbH, 8029 Sauerlach Dry-eye-packung
US5409904A (en) 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
FR2601385B1 (fr) * 1986-07-09 1989-09-29 Sucre Rech & Dev Procede de preparation a partir de saccharose d'un melange de sucres a haute teneur en isomaltose par voie enzymatique et produits obtenus
US4783488A (en) * 1987-01-31 1988-11-08 Bausch & Lomb Incorporated Contact lens wetting solution
US4767463A (en) * 1987-04-15 1988-08-30 Union Carbide Corporation Glycosaminoglycan and cationic polymer combinations
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5368843A (en) * 1988-06-08 1994-11-29 Lever Brothers Company, Division Of Conopco, Inc. Thickening system
US5204325A (en) * 1988-12-15 1993-04-20 Lindstrom Richard L Viscoelastic solution
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
JP2808378B2 (ja) * 1991-03-27 1998-10-08 武田薬品工業株式会社 水性懸濁液剤の製造法
RU2098094C1 (ru) * 1991-03-27 1997-12-10 Сендзю Фармасьютикал Ко., Лтд. Способ приготовления водной суспензии и водный глазной препарат
US5460834A (en) 1991-12-13 1995-10-24 Alcon Laboratories, Inc. Combinations of polymers for use in physiological tear compositions
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
JP2787131B2 (ja) * 1993-07-30 1998-08-13 千寿製薬株式会社 水性懸濁液剤
CN1085106A (zh) * 1993-10-27 1994-04-13 吴亮 眼科手术用带有荧光的粘弹性物质
CA2134376C (en) * 1993-12-20 2001-10-23 Haresh G. Bhagat Combinations of polymers for use in physiological tear compositions
ATE166227T1 (de) * 1994-03-18 1998-06-15 Senju Pharma Co Sarpogrelat enthaltende opthalmologische zubereitungen zur senkung des intraokularen druckes
SE9401108D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
WO1998043643A1 (fr) * 1997-04-01 1998-10-08 Toa Medicine Co., Ltd. Preparations d'une solution aqueuse d'acyclovir
DK1348427T3 (da) 1997-07-29 2008-06-30 Alcon Lab Inc Oftalmiske sammensætninger indeholdende galactomannanpolymerer og borater
ES2227331T3 (es) 1997-07-29 2005-04-01 Alcon Laboratories, Inc. Soluciones de acondicionamiento para el cuidado de las lentes de contacto duras.
EP0909558A3 (en) * 1997-08-29 1999-10-27 Santen Pharmaceutical Co., Ltd. Chroman derivative containing ophthalmic solution
GB9718568D0 (en) * 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
CN1158995C (zh) * 1998-01-22 2004-07-28 参天制药株式会社 氟米龙眼用混悬液
DE69923987T2 (de) * 1998-10-08 2006-11-02 Karagoezian, Hampar L., San Juan Capistrano Synergistische antimikrobielle, dermatologische und ophtahalmologische zubereitung, die ein chlorit und wasserstoffperoxid enthalten
US6174859B1 (en) * 1999-04-06 2001-01-16 J & D Sciences, Inc. Method of treatment
US7084130B2 (en) * 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
ATE459337T1 (de) * 2000-12-20 2010-03-15 Alcon Inc Intraoculare irrigationslösung mit verbesserten fliesseigenschaften
AR035509A1 (es) 2000-12-21 2004-06-02 Alcon Inc Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
JP3455852B2 (ja) * 2000-12-26 2003-10-14 株式会社オフテクス 洗眼液組成物
DK1347787T4 (da) * 2001-01-09 2011-01-03 Louis Johan Wagenaar Anvendelse af dexpanthenol i kontaktlinse-plejesammensætninger
JP2003137775A (ja) * 2001-10-31 2003-05-14 Menicon Co Ltd 眼科用組成物
US7001615B1 (en) * 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
JP2003183157A (ja) * 2001-12-19 2003-07-03 Lion Corp 眼科用組成物
US20040118414A1 (en) * 2002-12-20 2004-06-24 Shah Mandar V Surface modified viscoelastics for ocular surgery
WO2003059391A2 (en) 2001-12-21 2003-07-24 Alcon, Inc. Viscoelastics for ocular surgery
TW200400055A (en) * 2002-02-22 2004-01-01 Pharmacia Corp Ophthalmic formulation with novel gum composition
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
EP1624858B1 (en) * 2003-04-09 2018-06-06 Rutgers, the State University of New Jersey Novel encochleation methods
US20040241151A1 (en) * 2003-05-27 2004-12-02 Sca Hygiene Products Ab Polymer matrix with lactic acid producing bacteria
JP4694773B2 (ja) * 2003-06-06 2011-06-08 ロート製薬株式会社 粘膜適用液状組成物
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7914803B2 (en) * 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
TWM258789U (en) * 2004-06-09 2005-03-11 Ming-Hsiang Yeh Interactive toy
US20060003964A1 (en) 2004-06-30 2006-01-05 Shah Mandar V Dilution resistant viscoelastic compositions
BRPI0806967A2 (pt) * 2007-02-09 2014-04-08 Alcon Inc Composições oftálmicas contendo uma combinação sinérgica de três polímeros

Also Published As

Publication number Publication date
CA2839849C (en) 2017-03-07
ZA200509440B (en) 2007-04-25
ES2570856T3 (es) 2016-05-20
CA2527712A1 (en) 2004-12-29
CA2839847C (en) 2016-03-15
US20040253280A1 (en) 2004-12-16
CA2839928A1 (en) 2004-12-29
KR20110098863A (ko) 2011-09-01
EP2116227A2 (en) 2009-11-11
PT2116227E (pt) 2013-06-28
AU2004249137A1 (en) 2004-12-29
US7709012B2 (en) 2010-05-04
JP2011026354A (ja) 2011-02-10
CA2839898A1 (en) 2004-12-29
EP3028692A1 (en) 2016-06-08
AU2004249137B2 (en) 2010-03-11
BRPI0411361B1 (pt) 2017-05-23
WO2004112836A3 (en) 2005-06-16
CA2839928C (en) 2016-10-04
CA2527712C (en) 2014-08-05
ES2410505T3 (es) 2013-07-02
KR101131056B1 (ko) 2012-04-23
CA2839849A1 (en) 2004-12-29
KR101147046B1 (ko) 2012-05-22
ES2415738T3 (es) 2013-07-26
EP2361610B1 (en) 2013-04-24
KR20060012024A (ko) 2006-02-06
EP2116227B1 (en) 2013-04-24
JP2011184463A (ja) 2011-09-22
CA2839847A1 (en) 2004-12-29
AU2010200297A1 (en) 2010-02-18
KR20120062846A (ko) 2012-06-14
EP2361610A1 (en) 2011-08-31
EP2526929B1 (en) 2016-04-06
CN100475192C (zh) 2009-04-08
WO2004112836A8 (en) 2013-02-14
EP1631257A2 (en) 2006-03-08
EP2526929A8 (en) 2013-04-10
AU2010200297B2 (en) 2012-04-26
JP4860475B2 (ja) 2012-01-25
CA2839898C (en) 2017-01-24
JP2007500244A (ja) 2007-01-11
JP2013100360A (ja) 2013-05-23
SI2116227T1 (sl) 2013-07-31
EP2116227A3 (en) 2009-12-30
CA2839930C (en) 2016-07-05
WO2004112836A2 (en) 2004-12-29
BRPI0411361A (pt) 2006-07-25
KR20110032007A (ko) 2011-03-29
EP3028692B1 (en) 2020-04-22
EP2526929A1 (en) 2012-11-28
CA2839930A1 (en) 2004-12-29
CN1802147A (zh) 2006-07-12
DK2116227T3 (da) 2013-05-27
PL2116227T3 (pl) 2013-08-30
KR20110134525A (ko) 2011-12-14

Similar Documents

Publication Publication Date Title
MXPA05013290A (es) Composiciones oftalmicas que contienen una combinacion sinergistica de dos polimeros.
TW200501969A (en) Ophthalmic compositions containing a synergistic combination of three polymers
MX2009007774A (es) Composiciones oftalmicas que contienen una combinacion sinergistica de tres polimeros.
WO2004093795A3 (en) Compositions for delivery of drug combinations
TW200608973A (en) Rapamycin polymorph Ⅱ and uses thereof
LUC00065I2 (es)
IL173807A0 (en) Amphiphilic antioxidant compounds, mitoquinone derivatives and pharmaceutical compositions containing the same
TW200626132A (en) Topical nepafenac formulations
WO2005009460A3 (en) Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
JO2578B1 (en) Compounds Theophene benzimidazole
WO2002053519A3 (en) Hydrophobic polyamine analogs and methods for their use
TW200531686A (en) Pharmaceutical compositions
AU7918500A (en) Substituted diazepanes
UA83322C2 (en) Rubber formulation
AU2003273843A1 (en) Use of skin-protecting substances
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
WO2006044155A3 (en) Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same
PL380665A1 (pl) Farmaceutyczne kompozycje
WO2004018010A3 (en) Methods of drug delivery using sulphated chitinous polymers
AU2003272127A1 (en) Polymeric composition for drug delivery
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
TW200631589A (en) Varnish composition based on a solvent of plant origin
CY1114252T1 (el) Οφθαλμικες συνθεσεις περιεχουσες ενα συνεργιστικο συνδυασμο δυο πολυμερων
WO2006128120A3 (en) Novel lapachone compounds and methods of use thereof
WO2005048873A3 (en) Kit for administration of a drug

Legal Events

Date Code Title Description
FG Grant or registration